Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Return on Equity (2020 - 2025)

Historic Return on Equity for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to 0.41%.

  • Beam Therapeutics' Return on Equity fell 2500.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 0.44% for FY2024, which is 2800.0% down from last year.
  • Per Beam Therapeutics' latest filing, its Return on Equity stood at 0.41% for Q3 2025, which was down 2500.0% from 0.37% recorded in Q2 2025.
  • Beam Therapeutics' 5-year Return on Equity high stood at 0.14% for Q1 2024, and its period low was 0.91% during Q1 2021.
  • Its 5-year average for Return on Equity is 0.38%, with a median of 0.38% in 2023.
  • Per our database at Business Quant, Beam Therapeutics' Return on Equity soared by 20100bps in 2021 and then plummeted by -3400bps in 2024.
  • Beam Therapeutics' Return on Equity (Quarter) stood at 0.42% in 2021, then grew by 8bps to 0.38% in 2022, then surged by 63bps to 0.14% in 2023, then tumbled by -242bps to 0.49% in 2024, then rose by 15bps to 0.41% in 2025.
  • Its Return on Equity stands at 0.41% for Q3 2025, versus 0.37% for Q2 2025 and 0.42% for Q1 2025.